The Valve Chronicles: Pressure Control Guideline Differences in Aircraft Fueling Operations Between the US & Europe, Part 2

On this episode of The Valve Chronicles’ look at the differences in aircraft fueling operations between the US and Europe, Cla-Val’s Tom Boriack, Global Market Manager for Fueling, and Richard Hooton, Market Manager, Aviation & Ground Fueling, EMEA for Cla-Val Europe, joined host Tyler Kern for a discussion on the origins of vehicle design and the differences between the two regions. While Boriack might have felt as if Hooton had the edge over the past three episodes, could this be the discussion that finally handed the advantage over the United States?

Equipment design was the topic, but Boriack said one of the big standouts in the difference between the US and Europe was how each used the equipment. “People in the industry know we have hydrant systems,” Boriack said. “I think it’s something like 335 airports globally now which use hydrant vehicles for fueling aircraft. The remaining airports use refueling trucks, tanker trucks, bowsers.”

The most significant nuanced difference is the US uses stationary hydrant vehicles. Boriack said the US also used hydrant fueling trucks or dispensers. In Europe and globally, moving hydrant fueling trucks are the most relied on method. “They don’t really have stationary hydrant vehicles,” Boriack said.

There are many factors why the US utilizes stationary hydrant vehicles while Europe does not, and Hooton wanted to know why? One of the reasons, Boriack said, could have to do with the fact that many airlines have set gates within airports in the US, and in Europe, there is an open gate system. It is more challenging to have a stationary fueling setup when different aircraft types owned by several airlines are fueling at multiple gates.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More